Analyst Ratings for Jazz Pharmaceuticals (JAZZ)

JAZZ Rating Summary

JAZZ Price Target Summary

* Over Last 12-Mos
  |   Expand Research on JAZZ
Overall Rating: BUY   Rating Trend: Down   Avg. $ Target: $198.67 (+29.4%) * Over Last 12-Mos
Rating Score: 8.9 / 10   Percentile Rank: 88%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/14/2022 UBS Ashwani Verma New Coverage Buy
(N/A)
194.00
(N/A)
147.50
(153.49)
4.06% Details
4/6/2022 Goldman Sachs
» Updated 5/5/2022
Madhu Kumar Downgrade Neutral
(Buy)
201.00
(196.00)
160.73
(153.49)
-4.5% Details
Like JAZZ Ratings? Also take a look at AXSM, HOWL, PHM, FTV

JAZZ Ratings News